190 related articles for article (PubMed ID: 33991070)
21. The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival rates.
Meng F; Zhang L; Ren Y; Ma Q
J Cell Physiol; 2019 Jul; 234(7):10918-10925. PubMed ID: 30549039
[TBL] [Abstract][Full Text] [Related]
22. Identification of Key Genes Related to Lung Squamous Cell Carcinoma Using Bioinformatics Analysis.
Gao M; Kong W; Huang Z; Xie Z
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340320
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the Role and Regulation Mechanism of hsa-miR-147b in Lung Squamous Cell Carcinoma Based on The Cancer Genome Atlas Database.
Ke D; Guo Q; Fan TY; Xiao X
Cancer Biother Radiopharm; 2021 Apr; 36(3):280-291. PubMed ID: 33112657
[No Abstract] [Full Text] [Related]
24. Identification of a novel CpG methylation signature to predict prognosis in lung squamous cell carcinoma.
Lee N; Xia X; Meng H; Zhu W; Wang X; Zhang T; Zhang C; Zhang J; Luo P
Cancer Biomark; 2021; 30(1):63-73. PubMed ID: 32924987
[TBL] [Abstract][Full Text] [Related]
25. Human sperm-associated antigen 4 as a potential prognostic biomarker of lung squamous cell carcinoma.
Wang Y; Tang Y; Li J; Wang D; Li W
J Int Med Res; 2021 Jul; 49(7):3000605211032807. PubMed ID: 34311595
[TBL] [Abstract][Full Text] [Related]
26. Identification of 5 Gene Signatures in Survival Prediction for Patients with Lung Squamous Cell Carcinoma Based on Integrated Multiomics Data Analysis.
Ma H; Tong L; Zhang Q; Chang W; Li F
Biomed Res Int; 2020; 2020():6427483. PubMed ID: 32596344
[TBL] [Abstract][Full Text] [Related]
27. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
Yang Y; Wang M; Liu B
J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
[TBL] [Abstract][Full Text] [Related]
28. Identification of a novel glycolysis-related gene signature that can predict the survival of patients with lung adenocarcinoma.
Liu C; Li Y; Wei M; Zhao L; Yu Y; Li G
Cell Cycle; 2019 Mar; 18(5):568-579. PubMed ID: 30727821
[TBL] [Abstract][Full Text] [Related]
29. Development of alternative splicing signature in lung squamous cell carcinoma.
Yan JQ; Liu M; Ma YL; Le KD; Dong B; Li GH
Med Oncol; 2021 Mar; 38(5):49. PubMed ID: 33772655
[TBL] [Abstract][Full Text] [Related]
30. Identification of lncRNA biomarkers in lung squamous cell carcinoma using comprehensive analysis of lncRNA mediated ceRNA network.
Li R; Yang YE; Jin J; Zhang MY; Liu X; Liu XX; Yin YH; Qu YQ
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3246-3258. PubMed ID: 31364871
[TBL] [Abstract][Full Text] [Related]
31. Identification of seven-gene signature for prediction of lung squamous cell carcinoma.
Wang Z; Wang Z; Niu X; Liu J; Wang Z; Chen L; Qin B
Onco Targets Ther; 2019; 12():5979-5988. PubMed ID: 31440059
[No Abstract] [Full Text] [Related]
32. Identification and prognostic value of a glycolysis-related gene signature in patients with bladder cancer.
Wu Z; Wen Z; Li Z; Yu M; Ye G
Medicine (Baltimore); 2021 Jan; 100(3):e23836. PubMed ID: 33545950
[TBL] [Abstract][Full Text] [Related]
33. A Combined RNA Signature Predicts Recurrence Risk of Stage I-IIIA Lung Squamous Cell Carcinoma.
Sun L; Li J; Li X; Yang X; Zhang S; Wang X; Wang N; Xu K; Jiang X; Zhang Y
Front Genet; 2021; 12():676464. PubMed ID: 34194476
[TBL] [Abstract][Full Text] [Related]
34. Transcriptomic and functional network features of lung squamous cell carcinoma through integrative analysis of GEO and TCGA data.
Li Y; Gu J; Xu F; Zhu Q; Ge D; Lu C
Sci Rep; 2018 Oct; 8(1):15834. PubMed ID: 30367091
[TBL] [Abstract][Full Text] [Related]
35. GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma.
Ning J; Jiang S; Li X; Wang Y; Deng X; Zhang Z; He L; Wang D; Jiang Y
BMC Pulm Med; 2021 Jun; 21(1):199. PubMed ID: 34112123
[TBL] [Abstract][Full Text] [Related]
36. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
[TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNAs RP5-821D11.7, APCDD1L-AS1 and RP11-277P12.9 were associated with the prognosis of lung squamous cell carcinoma.
Luo Y; Xuan Z; Zhu X; Zhan P; Wang Z
Mol Med Rep; 2018 May; 17(5):7238-7248. PubMed ID: 29568882
[TBL] [Abstract][Full Text] [Related]
38. The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC.
Fu L; Wang H; Wei D; Wang B; Zhang C; Zhu T; Ma Z; Li Z; Wu Y; Yu G
PLoS One; 2020; 15(5):e0233283. PubMed ID: 32437446
[TBL] [Abstract][Full Text] [Related]
39. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma.
Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y
BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688
[TBL] [Abstract][Full Text] [Related]
40. Predicting the Lung Squamous Cell Carcinoma Diagnosis and Prognosis Markers by Unique DNA Methylation and Gene Expression Profiles.
Wang W; Wang S; Chu X; Liu H; Xiang M
J Comput Biol; 2020 Jul; 27(7):1041-1054. PubMed ID: 31710242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]